Differential Expression of Cellular and Exosomal MicroRNA Isolated from Oral Cancer Cells and their Resistance to Chemotherapy

B. Petersen, Carl Yu, S. Hutchings, Connor Lemmon, K. Howard, K. Kingsley
{"title":"Differential Expression of Cellular and Exosomal MicroRNA Isolated from Oral Cancer Cells and their Resistance to Chemotherapy","authors":"B. Petersen, Carl Yu, S. Hutchings, Connor Lemmon, K. Howard, K. Kingsley","doi":"10.3844/crdsp.2022.11.22","DOIUrl":null,"url":null,"abstract":": MicroRNAs are abundant small non-coding RNA with a variety of known functions, including transcriptional activation and inhibition. Recent evidence has suggested that microRNA expression may influence the responsiveness of some cancers to chemotherapy, including liver and lung cancers. Some evidence has now suggested that specific microRNAs, such as miR-21, miR-155, and miR-375, may influence oral cancer responsiveness to chemotherapy – although much remains to be discovered. Based on the lack of evidence in this area, the primary objective of this study was to evaluate microRNA expression and responsiveness among oral cancers. Five commercially available oral cancer cell lines (SCC4, SCC9, SCC15, SCC25, CAL27) were obtained from ATCC and cultured and chemotherapy resistance to Cisplatin, Fluorouracil or 5-FU and Paclitaxel or Taxol was assessed. Exosomes were then isolated, confirmed, and processed using Particle Metrix Nano Tracking Analysis (NTA) Subsequently, RNA was isolated from both the exosomes and cellular fractions and qPCR screening was performed to determine the expression of microRNA from cellular and exosomal isolates. Growth assays revealed that SCC15 assays were the least resistant, while CAL27 and SCC4 cells exhibited moderate resistance, and SCC9 and SCC25 cells exhibited strong and differential resistance to these chemotherapeutic agents. The screening revealed all cancers expressed miR-21 and miR-133 with differential expressions of miR-27, miR-135, miR-155, and miR-375 observed. However, the most resistant cell lines, SCC9 and SCC25, were the only cells to express miR-375 and were also the only cells that did not express miR-27, suggesting an association between chemotherapeutic resistance and expression of these specific microRNAs. In addition, miR-21 and miR-133 were identified in exosomes from all oral cancers with differential results observed with miR-133 and miR-135-although miR-27 and miR-375 were not found among any exosomes. Although much remains to be elucidated about the functional roles of these differentially expressed microRNAs, the findings of this study suggest that specific microRNAs including miR-27 and miR-375 may, in fact, function in distinct, different, and opposite pathways among these cell lines. Future research endeavors will need to evaluate the potential role of these microRNAs not only to validate their predictive capabilities as biomarkers but also to ascertain which functional pathways may be involved in the development and progression of oral cancers. corresponds 3.0  10 7 particles per mL for each sample. This analysis provides both the peak and mean diameter of EVs, including exosomes and nanospheres.","PeriodicalId":117844,"journal":{"name":"Current Research in Dentistry","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Dentistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3844/crdsp.2022.11.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

: MicroRNAs are abundant small non-coding RNA with a variety of known functions, including transcriptional activation and inhibition. Recent evidence has suggested that microRNA expression may influence the responsiveness of some cancers to chemotherapy, including liver and lung cancers. Some evidence has now suggested that specific microRNAs, such as miR-21, miR-155, and miR-375, may influence oral cancer responsiveness to chemotherapy – although much remains to be discovered. Based on the lack of evidence in this area, the primary objective of this study was to evaluate microRNA expression and responsiveness among oral cancers. Five commercially available oral cancer cell lines (SCC4, SCC9, SCC15, SCC25, CAL27) were obtained from ATCC and cultured and chemotherapy resistance to Cisplatin, Fluorouracil or 5-FU and Paclitaxel or Taxol was assessed. Exosomes were then isolated, confirmed, and processed using Particle Metrix Nano Tracking Analysis (NTA) Subsequently, RNA was isolated from both the exosomes and cellular fractions and qPCR screening was performed to determine the expression of microRNA from cellular and exosomal isolates. Growth assays revealed that SCC15 assays were the least resistant, while CAL27 and SCC4 cells exhibited moderate resistance, and SCC9 and SCC25 cells exhibited strong and differential resistance to these chemotherapeutic agents. The screening revealed all cancers expressed miR-21 and miR-133 with differential expressions of miR-27, miR-135, miR-155, and miR-375 observed. However, the most resistant cell lines, SCC9 and SCC25, were the only cells to express miR-375 and were also the only cells that did not express miR-27, suggesting an association between chemotherapeutic resistance and expression of these specific microRNAs. In addition, miR-21 and miR-133 were identified in exosomes from all oral cancers with differential results observed with miR-133 and miR-135-although miR-27 and miR-375 were not found among any exosomes. Although much remains to be elucidated about the functional roles of these differentially expressed microRNAs, the findings of this study suggest that specific microRNAs including miR-27 and miR-375 may, in fact, function in distinct, different, and opposite pathways among these cell lines. Future research endeavors will need to evaluate the potential role of these microRNAs not only to validate their predictive capabilities as biomarkers but also to ascertain which functional pathways may be involved in the development and progression of oral cancers. corresponds 3.0  10 7 particles per mL for each sample. This analysis provides both the peak and mean diameter of EVs, including exosomes and nanospheres.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口腔癌细胞和外泌体MicroRNA的差异表达及其对化疗的耐药性
MicroRNAs是一种丰富的小的非编码RNA,具有多种已知的功能,包括转录激活和抑制。最近的证据表明,microRNA的表达可能影响一些癌症对化疗的反应,包括肝癌和肺癌。一些证据表明,特定的microrna,如miR-21、miR-155和miR-375,可能会影响口腔癌对化疗的反应性——尽管还有很多有待发现。由于缺乏这方面的证据,本研究的主要目的是评估口腔癌中microRNA的表达和反应性。从ATCC中获得5株市售口腔癌细胞株(SCC4、SCC9、SCC15、SCC25、CAL27)并进行培养,评估对顺铂、氟尿嘧啶或5-FU以及紫杉醇或紫杉醇的化疗耐药性。然后,外泌体被分离、确认,并使用Particle Metrix纳米跟踪分析(NTA)进行处理。随后,从外泌体和细胞部分分离RNA,并进行qPCR筛选,以确定细胞和外泌体分离物中microRNA的表达。生长试验显示,SCC15细胞的耐药性最低,CAL27和SCC4细胞表现出中等耐药性,SCC9和SCC25细胞对这些化疗药物表现出强烈的差异耐药性。筛选发现所有肿瘤均表达miR-21和miR-133,并观察到miR-27、miR-135、miR-155和miR-375的差异表达。然而,最耐药的细胞系SCC9和SCC25是唯一表达miR-375的细胞,也是唯一不表达miR-27的细胞,这表明化疗耐药与这些特异性microrna的表达之间存在关联。此外,在所有口腔癌的外泌体中发现了miR-21和miR-133, miR-133和mir -135的结果不同,尽管在任何外泌体中未发现miR-27和miR-375。尽管这些差异表达的microrna的功能作用仍有待阐明,但本研究的结果表明,包括miR-27和miR-375在内的特定microrna实际上可能在这些细胞系中以不同的、不同的和相反的途径起作用。未来的研究工作将需要评估这些microrna的潜在作用,不仅要验证它们作为生物标志物的预测能力,还要确定哪些功能途径可能参与口腔癌的发生和进展。每个样品对应3.010.7颗粒/ mL。该分析提供了ev的峰值和平均直径,包括外泌体和纳米球。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Dental Color Matching: A Comparison between Visual and Digital Shade Selection Repeatability in the Anterior and Posterior Region: A Clinical Study Microleakage Assessment of CAD/CAM Endo Crown Restorations (an in vitro Study) Survey on Oral Health and History of Muscle Injury in Professional Athletes of Brazilian Women's Soccer: A Cross-Sectional Self-Reported Study Differential Expression of Cellular and Exosomal MicroRNA Isolated from Oral Cancer Cells and their Resistance to Chemotherapy The Anti-Nociceptive/Anti-Inflammatory Actions of Botulinum Toxin A for the Treatment of Chronic Pain; A Literature Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1